Morbid obesity increases the failure rate of sentinel lymph node mapping for endometrial carcinoma
Authors:
- 6 May 2023
- journal article
- research article
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 17 (5) , 2047-2052
Abstract
The goal of this study was to examine the relationship between body mass index (BMI) and the success rate of sentinel lymph node (SLN) mapping using indocyanine green and near-infrared imaging. Sentinel lymph node mapping is recommended for patients with endometrial carcinoma to reduce the rate of full lymphadenectomy and its associated morbidity such as lymphedema. A retrospective review was conducted of robotic hysterectomy procedures for patients with a coded diagnosis of endometrial cancer and a cost code for indocyanine green discharged between March, 2016 and August, 2019. Preoperative characteristics included age, BMI, and number of prior abdominal surgeries (includes cervical, adnexal, uterine or rectal procedures, caesarian section, or appendectomy). Intra and postoperative characteristics included procedure time (incision to close), estimated blood loss, the American Society of Anesthesiologists (ASA) physical status classification, uterine weight, uterine diameter, FIGO Grade, myometrial depth, and depth of myometrial invasion. SLN and non-SLN number, location, and pathology were recorded. The primary outcome was the bilateral success rate for SLN mapping. Patients with class III obesity (BMI > 40) were found to have a significantly lower success rate for SLN mapping when compared with all other BMI categories (54.1% vs. 76.1%, respectively, p < 0.01).Keywords
This publication has 13 references indexed in Scilit:
- Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancerGynecologic Oncology, 2019
- Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine GreenGynecologic and Obstetric Investigation, 2019
- Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancerGynecologic Oncology, 2018
- Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendationsGynecologic Oncology, 2017
- A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine CancerInternational Journal of Gynecological Cancer, 2017
- Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology, 2017
- Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic SurgeryAnnals of Surgical Oncology, 2016
- Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancerGynecologic Oncology, 2015
- A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancerGynecologic Oncology, 2014
- Type I and II Endometrial Cancers: Have They Different Risk Factors?Journal of Clinical Oncology, 2013